Near infrared photoimmunotherapy: a review of recent progress and their target molecules for cancer therapy
TM Mohiuddin, C Zhang, W Sheng, M Al-Rawe… - International journal of …, 2023 - mdpi.com
Near infrared photoimmunotherapy (NIR-PIT) is a newly developed molecular targeted
cancer treatment, which selectively kills cancer cells or immune-regulatory cells and induces …
cancer treatment, which selectively kills cancer cells or immune-regulatory cells and induces …
[HTML][HTML] Near infrared photoimmunotherapy; a review of targets for cancer therapy
Simple Summary Near-infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer
treatment that uses an antibody-photoabsorber (IRDye700DX) conjugate (APC) that is …
treatment that uses an antibody-photoabsorber (IRDye700DX) conjugate (APC) that is …
Treg-dominant tumor microenvironment is responsible for hyperprogressive disease after PD-1 blockade therapy
Abstract Programmed cell death 1 (PD-1) blockade therapy can result in dramatic responses
in some patients with cancer. However, about 15% of patients receiving PD-1 blockade …
in some patients with cancer. However, about 15% of patients receiving PD-1 blockade …
Phototruncation cell tracking with near-infrared photoimmunotherapy using heptamethine cyanine dye to visualise migratory dynamics of immune cells
Background Noninvasive in vivo cell tracking is valuable in understanding the mechanisms
that enhance anti-cancer immunity. We have recently developed a new method called …
that enhance anti-cancer immunity. We have recently developed a new method called …
Near infrared photoimmunotherapy for cancers: A translational perspective
Near-infrared photoimmunotherapy (NIR-PIT) is a newly-developed, highly-selective cancer
treatment, which utilizes a monoclonal antibody conjugated to a photoabsorbing dye …
treatment, which utilizes a monoclonal antibody conjugated to a photoabsorbing dye …
Quickly evolving near‐infrared photoimmunotherapy provides multifaceted approach to modern cancer treatment
Among modalities of cancer immunotherapy, near‐infrared photoimmunotherapy (NIR‐PIT)
has reached significant preclinical and clinical stages and quickly evolved over the last 5 …
has reached significant preclinical and clinical stages and quickly evolved over the last 5 …
The mouse oral carcinoma (MOC) model: a 10-year retrospective on model development and head and neck cancer investigations
Preclinical models of cancer have long been paramount to understanding tumor
development and advancing the treatment of cancer. Creating preclinical models that mimic …
development and advancing the treatment of cancer. Creating preclinical models that mimic …
Adrenergic receptor signaling regulates the CD40-receptor mediated anti-tumor immunity
Introduction Anti-CD40 agonistic antibody (αCD40), an activator of dendritic cells (DC) can
enhance antigen presentation and activate cytotoxic T-cells against poorly immunogenic …
enhance antigen presentation and activate cytotoxic T-cells against poorly immunogenic …
Simultaneously combined cancer cell-and CTLA4-targeted NIR-PIT causes a synergistic treatment effect in syngeneic mouse models
Near-infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment that utilizes
antibody–IRDye700DX (IR700) conjugates. The clinical use of NIR-PIT has recently been …
antibody–IRDye700DX (IR700) conjugates. The clinical use of NIR-PIT has recently been …
Near‐infrared photoimmunotherapy targeting PD‐L1: Improved efficacy by preconditioning the tumor microenvironment
Near‐infrared photoimmunotherapy (NIR‐PIT) is a new type of cancer therapy that employs
antibody‐IRDye700DX conjugates (AbPCs) and near‐infrared (NIR) light at a wavelength of …
antibody‐IRDye700DX conjugates (AbPCs) and near‐infrared (NIR) light at a wavelength of …